Flavia Vieira
Salvador, BA, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Measuring suicidal behavior in the era of rapid-acting antidepressants: A systematic review of ketamine studies.
Journal: Psychiatry research
Published: November 19, 2024
Ketamine for catatonia: A novel treatment for an old clinical challenge? A systematic review of the evidence.
Journal: Schizophrenia research
Published: April 28, 2024
Arketamine for bipolar depression: Open-label, dose-escalation, pilot study.
Journal: Journal of psychiatric research
Published: February 07, 2023
Arketamine as adjunctive therapy for treatment-resistant depression: A placebo-controlled pilot study.
Journal: Journal of affective disorders
Published: January 11, 2023
Does the intensity of dissociation predict antidepressant effects 24 hours after infusion of racemic ketamine or esketamine in treatment-resistant depression? A secondary analysis from a randomized controlled trial.
Journal: Trends in psychiatry and psychotherapy
Published: November 17, 2022
Esketamine for Unipolar Major Depression With Psychotic Features: A Retrospective Chart Review and Comparison With Nonpsychotic Depression.
Journal: Journal of clinical psychopharmacology
Published: June 21, 2022
Letter to the Editor: Antidepressant and Antisuicidal Effects of Esketamine in Adolescents with Major Depressive Disorder and Suicidal Ideation: A Case Series.
Journal: Journal of child and adolescent psychopharmacology
Published: June 16, 2022
Suicide attempt, impulsivity, and exposure to trauma in college students.
Journal: Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)
Published: August 10, 2021
Neurocognitive Effects of Ketamine and Esketamine for Treatment-Resistant Major Depressive Disorder: A Systematic Review.
Journal: Harvard review of psychiatry
Published: August 09, 2021
Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment-resistant depression.
Journal: Human psychopharmacology
Published: July 16, 2021
Neuropsychological effects of direct-acting antiviral treatment for Hepatitis C virus subjects: A systematic review.
Journal: Journal of viral hepatitis
Published: May 05, 2021
Brain-derived neurotrophic factor serum levels following ketamine and esketamine intervention for treatment-resistant depression: secondary analysis from a randomized trial.
Journal: Trends in psychiatry and psychotherapy
Published: April 26, 2021
Last Updated: 09/26/2026